Blood Banking Market Report

Blood Banking Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Feb 25, 2020
  • PAGES：162
  • REPORT CODE：GMM484237
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Blood Banking market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period.

    This report presents the market size and development trends by detailing the Blood Banking market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Blood Banking market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Blood Banking industry and will help you to build a panoramic view of the industrial development.

    Blood Banking Market, By Type:

    • Type 1

    • Type 2

    • Type 3

    Blood Banking Market, By Application:

    • End-User 1

    • End-User 2

    • End-User 3

    Some of the leading players are as follows:

    • Octapharma

    • Sichuan Yuanda Shuyang

    • Kawasumi

    • New York Blood Center

    • bioMérieux

    • Haemonetics

    • MacoPharma

    • American Red Cross

    • Canadian Blood Services

    • Kedrion

    • BD

    • Fresenius Kabi

    • Hualan Bio

    • Grifols

    • Cerus

    • America’s Blood Centers

    • Biotest

    • Shire (Baxalta)

    • Immucor

    • RAAS

    • Ortho-Clinical

    • Japan Red Cross Society

    • Beckman Coulter

    • Terumo BCT

    • Bio-Rad Laboratories

    • Abbott

    • CSL

    • Sanquin Blood Supply Foundation

    • LFB Group

    • CBPO

    • BPL

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Blood Banking Market: Technology Type Analysis

    • 4.1 Blood Banking Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Blood Banking Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Type 1

      • 4.3.2 Type 2

      • 4.3.3 Type 3

    5 Blood Banking Market: Product Analysis

    • 5.1 Blood Banking Product Market Share Analysis, 2018 & 2026

    • 5.2 Blood Banking Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Blood Banking Market: Application Analysis

    • 6.1 Blood Banking Application Market Share Analysis, 2018 & 2026

    • 6.2 Blood Banking Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 End-User 1

      • 6.3.2 End-User 1

      • 6.3.3 End-User 3

    7 Blood Banking Market: Regional Analysis

    • 7.1 Blood Banking Regional Market Share Analysis, 2018 & 2026

    • 7.2 Blood Banking Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Octapharma

      • 9.1.1 Octapharma Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Sichuan Yuanda Shuyang

      • 9.2.1 Sichuan Yuanda Shuyang Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Kawasumi

      • 9.3.1 Kawasumi Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 New York Blood Center

      • 9.4.1 New York Blood Center Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 bioMérieux

      • 9.5.1 bioMérieux Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Haemonetics

      • 9.6.1 Haemonetics Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 MacoPharma

      • 9.7.1 MacoPharma Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 American Red Cross

      • 9.8.1 American Red Cross Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Canadian Blood Services

      • 9.9.1 Canadian Blood Services Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Kedrion

      • 9.10.1 Kedrion Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 BD

      • 9.11.1 BD Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Fresenius Kabi

      • 9.12.1 Fresenius Kabi Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Hualan Bio

      • 9.13.1 Hualan Bio Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Grifols

      • 9.14.1 Grifols Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Cerus

      • 9.15.1 Cerus Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 America’s Blood Centers

      • 9.16.1 America’s Blood Centers Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Biotest

      • 9.17.1 Biotest Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 Shire (Baxalta)

      • 9.18.1 Shire (Baxalta) Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 Immucor

      • 9.19.1 Immucor Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 RAAS

      • 9.20.1 RAAS Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

    • 9.21 Ortho-Clinical

      • 9.21.1 Ortho-Clinical Company overview

      • 9.21.2 Financial performance

      • 9.21.3 Product benchmarking

      • 9.21.4 Strategic initiatives

      • 9.21.5 SWOT analysis

    • 9.22 Japan Red Cross Society

      • 9.22.1 Japan Red Cross Society Company overview

      • 9.22.2 Financial performance

      • 9.22.3 Product benchmarking

      • 9.22.4 Strategic initiatives

      • 9.22.5 SWOT analysis

    • 9.23 Beckman Coulter

      • 9.23.1 Beckman Coulter Company overview

      • 9.23.2 Financial performance

      • 9.23.3 Product benchmarking

      • 9.23.4 Strategic initiatives

      • 9.23.5 SWOT analysis

    • 9.24 Terumo BCT

      • 9.24.1 Terumo BCT Company overview

      • 9.24.2 Financial performance

      • 9.24.3 Product benchmarking

      • 9.24.4 Strategic initiatives

      • 9.24.5 SWOT analysis

    • 9.25 Bio-Rad Laboratories

      • 9.25.1 Bio-Rad Laboratories Company overview

      • 9.25.2 Financial performance

      • 9.25.3 Product benchmarking

      • 9.25.4 Strategic initiatives

      • 9.25.5 SWOT analysis

    • 9.26 Abbott

      • 9.26.1 Abbott Company overview

      • 9.26.2 Financial performance

      • 9.26.3 Product benchmarking

      • 9.26.4 Strategic initiatives

      • 9.26.5 SWOT analysis

    • 9.27 CSL

      • 9.27.1 CSL Company overview

      • 9.27.2 Financial performance

      • 9.27.3 Product benchmarking

      • 9.27.4 Strategic initiatives

      • 9.27.5 SWOT analysis

    • 9.28 Sanquin Blood Supply Foundation

      • 9.28.1 Sanquin Blood Supply Foundation Company overview

      • 9.28.2 Financial performance

      • 9.28.3 Product benchmarking

      • 9.28.4 Strategic initiatives

      • 9.28.5 SWOT analysis

    • 9.29 LFB Group

      • 9.29.1 LFB Group Company overview

      • 9.29.2 Financial performance

      • 9.29.3 Product benchmarking

      • 9.29.4 Strategic initiatives

      • 9.29.5 SWOT analysis

    • 9.30 CBPO

      • 9.30.1 CBPO Company overview

      • 9.30.2 Financial performance

      • 9.30.3 Product benchmarking

      • 9.30.4 Strategic initiatives

      • 9.30.5 SWOT analysis

    • 9.31 BPL

      • 9.31.1 BPL Company overview

      • 9.31.2 Financial performance

      • 9.31.3 Product benchmarking

      • 9.31.4 Strategic initiatives

      • 9.31.5 SWOT analysis

     

    The List of Tables and Figures (Totals 99 Figures and 122 Tables)

    • Figure Type 1 Blood Banking market, 2015 - 2026 (USD Million)

    • Figure Type 2 Blood Banking market, 2015 - 2026 (USD Million)

    • Figure Type 3 Blood Banking market, 2015 - 2026 (USD Million)

    • Figure End-User 1 market, 2015 - 2026 (USD Million)

    • Figure End-User 2 market, 2015 - 2026 (USD Million)

    • Figure End-User 3 market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Blood Banking market, by country, 2015 - 2026 (USD Million)

    • Table North America Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table North America Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table North America Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Canada Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Canada Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Europe Blood Banking market, by country, 2015 - 2026 (USD Million)

    • Table Europe Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Europe Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Europe Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Germany Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Germany Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table France Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table France Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Italy Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Italy Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Spain Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Spain Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blood Banking market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table China Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table China Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Japan Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Japan Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table India Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table India Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Blood Banking market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table MEA Blood Banking market, by country, 2015 - 2026 (USD Million)

    • Table MEA Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table MEA Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table MEA Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Blood Banking market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Blood Banking market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Blood Banking market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Octapharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sichuan Yuanda Shuyang Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kawasumi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table New York Blood Center Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table bioMérieux Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Haemonetics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table MacoPharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table American Red Cross Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Canadian Blood Services Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kedrion Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BD Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fresenius Kabi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hualan Bio Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Grifols Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cerus Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table America’s Blood Centers Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biotest Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shire (Baxalta) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Immucor Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table RAAS Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ortho-Clinical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Japan Red Cross Society Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Beckman Coulter Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Terumo BCT Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CSL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanquin Blood Supply Foundation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table LFB Group Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table CBPO Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BPL Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US